Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-27T13:30:07.928Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of ALS IgG on Motor Neurons in Organotypic Spinal Cord Cultures

Published online by Cambridge University Press:  02 December 2014

Bin Li ,
Xiao-Yun Liu ,
Zhe Li ,
Hui Bu ,
Meng-Meng Sun ,
Yan-Su Guo  and
Chun-Yan Li
Bin Li
Affiliation:
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang
Xiao-Yun Liu
Affiliation:
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, People’s Republic of China
Zhe Li
Affiliation:
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang
Hui Bu
Affiliation:
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, People’s Republic of China
Meng-Meng Sun
Affiliation:
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang
Yan-Su Guo
Affiliation:
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, People’s Republic of China
Chun-Yan Li*
Affiliation:
Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang Institute of Cardiocerebrovascular Disease, Shijiazhuang, Hebei, People’s Republic of China
*
Department of Neurology, the Second Hospital of Hebei Medical University, Institute of Cardiocerebrovascular Disease, Hepingxi Road 215, Shijiazhuang, Hebei, People’s Republic of China, 050000.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Reports about the role of autoimmunity in amyotrophic lateral sclerosis (ALS) are inconsistent. The aim of this work was to investigate the effect of IgG from patients with ALS on motor neurons in a physiological-like surrounding.

Methods:

Using affinity chromatography, IgG from six ALS patients, four disease controls and five healthy subjects was purified. Organotypic spinal cord cultures, which conserve the structure of the spinal cord in a horizontal plane and are suitable for studies with long-term treatment, were used and IgG with different concentrations ranging from 0.05 mg/mL to 0.5 mg/mL was added to the culture medium. Ventral motor neuron survival was evaluated by morphology and SMI-32 immunohistochemistry staining. Lactate dehydrogenase (LDH) level in the culture medium was measured by colorimetry.

Results:

After cultures were treated with ALS IgG for three weeks, the number and morphology of motor neurons showed little change. In addition, there was no significant difference in lactate dehydrogenase release between cultures treated with medium alone, normal control IgG, disease control IgG or ALS IgG.

Conclusions:

The results indicate that IgG from these ALS patients was insufficient per se to induce motor neuron death in Organotypic slice cultures. However, this does not preclude the possibility that other changes may have occurred in the motor neurons. This work offered a new model to evaluate the role of IgG in the pathogenesis of ALS. Organotypic cultures contribute to study of the impact of IgG on motor neurons by mimicking physiological conditions.

résumé:

<span class='bold'>RÉSUMÉ:</span> <span class='bold'> <span class='italic'>Objectif:</span></span>

Les données sur le röle de l'autoimmunité dans la genèse de la sclérose latérale amyotrophique (SLA) sont contradictoires. Le but de cette étude était de déterminer quels sont les effets d'IgG provenant de patients atteints de SLA sur des neurones moteurs dans un milieu simulant le milieu physiologique.

<span class='bold'> <span class='italic'>Méthodes:</span></span>

Des IgG provenant de six patients atteints de SLA, de quatre patients atteints d’autres maladies et de cinq sujets sains ont été purifiées par chromatographie d’affinité. Des cultures organotypiques de moelle épinière qui conservent la structure de la moelle épinière sur un plan horizontal et qui sont adéquates pour des études à long terme, ont été utilisées. Des IgG à différentes concentrations, allant de 0,05 mg/mL à 0,5 mg/mL, ont été ajoutées au milieu de culture. La survie des neurones moteurs antérieurs a été évaluée par examen morphologique et par coloration immunohistochimique au SMI–32. Le niveau de déshydrogénase lactique (DHL) dans le milieu de culture a été mesuré par colorimétrie.

<span class='bold'> <span class='italic'>Résultats:</span></span>

: Le nombre et la morphologie des neurones moteurs étaient pratiquement inchangés après trois semaines de traitement des cultures par des IgG provenant de patients atteints de SLA. De plus, il n'existait pas de différence significative dans la libération de DHL entre les cellules cultivées dans le milieu de culture sans ajout, le milieu de culture contenant des IgG de sujets témoins normaux, le milieu de culture contenant des IgG de patients atteints d’autres maladies et le milieu de culture contenant des IgG de patients atteints de SLA.

<span class='bold'> <span class='italic'>Conclusion:</span></span>

Ces résultats indiquent que les IgG des patients atteints de SLA n’étaient pas suffisantes pour induire la mort de neurones moteurs en cultures organotypiques de coupes de tissus. Cependant, ceci n’exclut pas la possibilité que d’autres changements étaient présents dans les neurones moteurs. Cette étude représente un nouveau modèle pour évaluer le röle des IgG dans la pathogenèse de la SLA. Les cultures organotypiques contribuent à l’étude de l’impact des IgG sur les neurones moteurs en imitant les conditions physiologiques.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 35 , Issue 2 , May 2008 , pp. 220 - 225
Copyright
Copyright © The Canadian Journal of Neurological 2008

References

1. Appel, SH, Glenn-Smith, R, Alexianu, M, Siklos, L, Engelhardt, J, Colom, LV, et al. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clin Neurosci. 1995; 3(6):368–74.Google ScholarPubMed
2. Engelhardt, JI, Appel, SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol. 1990; 47(11):1210–6.CrossRefGoogle ScholarPubMed
3. Alexianu, ME, Kozovska, M, Appel, SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001; 57(7):1282–9.Google Scholar
4. Li, F, Pestronk, A. Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders. J Neurol Sci. 1991; 104(2): 209–14.Google Scholar
5. Smith, RG, Hamilton, S, Hofmann, F, Schneider, T, Nastainczyk, W, Birnbaumer, L, et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med. 1992; 327(24):1721–8.Google Scholar
6. Kimura, F, Smith, RG, Delbono, O, Nyormoi, O, Schneider, T, Nastainczyk, W, et al. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Ann Neurol. 1994; 35(2): 164–71.Google Scholar
7. Couratier, P, Yi, FH, Preud’homme, JL, Clavelou, P, White, A, Sindou, P, et al. Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis. J Neurol Sci. 1998; 154(2): 137–45.Google Scholar
8. Yi, FH, Lautrette, C, Vermot-Desroches, C, Bordessoule, D, Couratier, P, Wijdenes, J, et al. In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol. 2000; 109(2):211–20.CrossRefGoogle ScholarPubMed
9. Sengun, IS, Appel, SH. Serum anti-Fas antibody levels in amyotrophic lateral sclerosis. J Neuroimmunol. 2003; 142(1-2): 137–40.Google Scholar
10. Engelhardt, JI, Siklos, L, Komuves, L, Smith, RG, Appel, SH. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse. 1995; 20(3):185–99.Google Scholar
11. Pullen, AH, Humphreys, P. Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls. J Neurol Sci. 2000; 180(1-2):35–45.Google Scholar
12. Obal, I, Siklos, L, Engelhardt, JI. Altered calcium in motoneurons by IgG from human motoneuron diseases. Acta Neurol Scand. 2002; 106(5):282–91.CrossRefGoogle ScholarPubMed
13. Pullen, AH, Demestre, M, Howard, RS, Orrell, RW. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement. ActaNeuropathol. 2004; 107(1):35–46.Google Scholar
14. Smith, RG, Alexianu, ME, Crawford, G, Nyormoi, O, Stefani, E, Appel, SH. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci USA. 1994; 91(8):3393–7.CrossRefGoogle ScholarPubMed
15. Alexianu, ME, Mohamed, AH, Smith, RG, Colom, LV, Appel, SH. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J Neurochem. 1994; 63(6):2365–8.CrossRefGoogle ScholarPubMed
16. Demestre, M, Pullen, A, Orrell, RW, Orth, M. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J Neurochem. 2005; 94(1):268–75.Google Scholar
17. Arsac, C, Raymond, C, Martin-Moutot, N, Dargent, B, Couraud, F, Pouget, J, et al. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann Neurol. 1996; 40(5):695–700.Google Scholar
18. Drachman, DB, Fishman, PS, Rothstein, JD, Motomura, M, Lang, B, Vincent, A, et al. Amyotrophic lateral sclerosis. An autoimmune disease? Adv Neurol. 1995; 68:59–65.Google Scholar
19. Nyormoi, O. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations. Ann Neurol. 1996; 40(5):701–6.CrossRefGoogle ScholarPubMed
20. Bar, PR. Motor neuron disease in vitro: the use of cultured motor neurons to study amyotrophic lateral sclerosis. Eur J Pharmacol. 2000; 405(1-3):285–95.Google Scholar
21. Rothstein, JD, Jin, L, Dykes-Hoberg, M, Kuncl, RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA. 1993; 90(14):6591–5.Google Scholar
22. Drachman, DB, Rothstein, JD. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol. 2000; 48(5):792–5.3.0.CO;2-5>CrossRefGoogle Scholar
23. Stoppini, L, Buchs, PA, Muller, D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods. 1991; 37(2): 173–82.CrossRefGoogle ScholarPubMed
24. Noraberg, J, Kristensen, BW, Zimmer, J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc. 1999; 3(3):278–90.Google Scholar
25. Zhao, W, Xie, W, Le, W, Beers, DR, He, Y, Henkel, JS, et al. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol. 2004; 63(9):964–77.Google Scholar